Latest Breaking News On - Pharmasset inc - Page 1 : comparemela.com

Triumvira Immunologics Appoints Life Sciences Industry Leader Robert Williamson as President and Chief Business Officer

Triumvira Immunologics, Inc. (“Triumvira”), a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with cancer, today announced the appointment of Robert Williamson as President and Chief Business Officer .

United statesPaul lammersRobert williamsonPomona collegeEos biotechnology incTriumvira immunologics incMaster of business administrationProgen pharmaceuticalsBiotheryx incArriva pharmaceuticals incBoston consulting groupDoubletwist incPharmakea incStanford university graduate school of businessPharmasset incChief business

Resolution Therapeutics Appoints Dr Bill Symonds to its Board of Directors

Resolution Therapeutics Appoints Dr Bill Symonds to its Board of Directors
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesCity ofUnited kingdomEdward hodgkinDevelopment officerCampbell universityRoivant sciences incPartner of syncona investment managementEnzyvant sciencesAltavant sciencesResolution therapeutics limitedPharmasset incBill symondsNon executive directorSyncona investment management limited

Everything You Need To Know About Molnupiravir, Merck s New High-hope COVID Drug

Everything You Need To Know About Molnupiravir, Merck s New High-hope COVID Drug
science.thewire.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from science.thewire.in Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyRidgeback biotherapeuticsGilead sciencesEmory universityDrug administrationMerck coUniversity of north carolinaEuropean medicines agencyPharmasset incScience newsNorth carolina

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation

VIC Technology Venture Development Announces New Additions to Strategic Advisory Board, Bringing Together Industry Veterans to Guide Medical Innovation Share Article Dr. Dennis Liotta and Dr. Paul Atkins “They are both innovative, life science veterans that have taken impactful technologies from the earliest stage to highly successful exits and we are fortunate to have them on our team.” said Calvin Goforth, Chief Executive Officer of VIC. FAYETTEVILLE, Ark. (PRWEB) May 17, 2021 VIC Technology Venture Development, which creates and develops high impact life science companies based on technologies exclusively licensed from top research institutions worldwide, announced today two new distinguished additions to their Strategic Advisory Board from across the life science industry.

United statesAl gorePaul atkinsBaeg choiDennis liottaCalvin goforthRaymondf schinaziEmory institute for drug developmentGilead sciencesChemical technical options committeeIntergovernmental panel on climateTechnology venture developmentUnited nationsAmerican chemical societyIntergovernmental panel on climate changePharmasset inc